PRINCETON, NJ -- (MARKET WIRE) -- February 22, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, is scheduled to provide a company update at the SIGnificant Investment Options in Healthcare Conference.
